Rhumbline Advisers Revolution Medicines, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 226,992 shares of RVMD stock, worth $12.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
226,992
Previous 228,567 0.69%
Holding current value
$12.8 Million
Previous $8.87 Million 15.95%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$36.92 - $47.94 $58,149 - $75,505
-1,575 Reduced 0.69%
226,992 $10.3 Million
Q2 2024

Aug 01, 2024
BUY
$30.14 - $40.68 $580,405 - $783,374
19,257 Added 9.2%
228,567 $8.87 Million
Q1 2024

May 09, 2024
BUY
$26.56 - $33.55 $104,965 - $132,589
3,952 Added 1.92%
209,310 $6.75 Million
Q4 2023

Feb 08, 2024
BUY
$18.35 - $34.12 $1.1 Million - $2.04 Million
59,786 Added 41.07%
205,358 $5.89 Million
Q3 2023

Nov 09, 2023
BUY
$25.17 - $35.05 $173,521 - $241,634
6,894 Added 4.97%
145,572 $4.03 Million
Q2 2023

Aug 08, 2023
BUY
$20.28 - $27.0 $106,733 - $142,101
5,263 Added 3.94%
138,678 $3.71 Million
Q1 2023

May 11, 2023
BUY
$20.76 - $30.09 $304,715 - $441,661
14,678 Added 12.36%
133,415 $2.89 Million
Q4 2022

Feb 14, 2023
BUY
$17.68 - $25.53 $188,026 - $271,511
10,635 Added 9.84%
118,737 $2.83 Million
Q3 2022

Nov 10, 2022
BUY
$17.46 - $26.0 $300,294 - $447,174
17,199 Added 18.92%
108,102 $2.13 Million
Q2 2022

Aug 11, 2022
BUY
$14.54 - $27.17 $217,518 - $406,463
14,960 Added 19.7%
90,903 $1.77 Million
Q1 2022

May 12, 2022
SELL
$17.31 - $26.4 $71,196 - $108,583
-4,113 Reduced 5.14%
75,943 $1.94 Million
Q4 2021

Feb 10, 2022
SELL
$24.35 - $33.7 $18,359 - $25,409
-754 Reduced 0.93%
80,056 $2.02 Million
Q3 2021

Nov 12, 2021
BUY
$23.95 - $33.41 $62,485 - $87,166
2,609 Added 3.34%
80,810 $2.22 Million
Q2 2021

Aug 05, 2021
BUY
$29.0 - $47.44 $939,803 - $1.54 Million
32,407 Added 70.77%
78,201 $2.48 Million
Q1 2021

May 06, 2021
SELL
$37.21 - $54.43 $19,832 - $29,011
-533 Reduced 1.15%
45,794 $2.1 Million
Q4 2020

Feb 10, 2021
BUY
$30.19 - $45.49 $144,881 - $218,306
4,799 Added 11.56%
46,327 $1.83 Million
Q3 2020

Nov 12, 2020
BUY
$22.61 - $34.8 $513,676 - $790,621
22,719 Added 120.79%
41,528 $1.45 Million
Q2 2020

Aug 13, 2020
BUY
$19.65 - $39.34 $88,169 - $176,518
4,487 Added 31.33%
18,809 $594,000
Q1 2020

May 06, 2020
BUY
$20.0 - $34.08 $286,440 - $488,093
14,322 New
14,322 $314,000

Others Institutions Holding RVMD

# of Institutions
266
Shares Held
161M
Call Options Held
260K
Put Options Held
620K
View Full List

About Revolution Medicines, Inc.

RVMD Quotes by TradingView
  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $4.95B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email